Kardiyak Resenkronizasyon Tedavisi Yanıt Tanımı ve İlişkili Faktörler

Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/ HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmic Devices). Circulation 2008;117:e350–408.

Rickard J, Cheng A, Spragg D, et al. Durability of the survival effect of cardiac resynchronization therapy by level of left ventricular functional improvement: fate of ‘‘nonresponders’’. Heart Rhythm 2014;11:412–6.

Zareba W, Klein H, Cygankiewicz I, et al. MADIT-CRT Investigators. Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT). Circulation 2011;123(10):1061–1072.

Varma N, Manne M, Nguyen D, et al. Probability and magnitude of response to cardiac resynchronization therapy according to QRS duration and gender in nonischemic cardiomyopathy and LBBB. Heart Rhythm 2014;11:1139–47.

Leyva F, Foley PW, Chalil S, et al. Cardiac resynchronization therapy guided by late gadolinium-enhancement cardiovascular magnetic resonance. Journal of Cardiovascular Magnetic Resonance 2011;13:29.

Cleland JG, Daubert JC, Erdmann E, et al; Cardiac Resyn-chronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. New England Journal of Medicine 2005;352:1539–49.

Yu CM, Chau E, Sanderson JE, et al. Tissue Doppler echo-cardiographic evidence of reverse remodeling and improved synchronicity by simultaneously delaying regional contraction after biventricular pacing therapy in heart failure. Circulation. 2002;105:438–45.

Bax JJ, Abraham T, Barold SS, et al. Cardiac resynchronization therapy: Part 1–issues before device implantation. Journal of the American College of Cardiology 2005;46:2153–67.

Ghio S, Constantin C, Klersy C, et al. Interventricular and intraventricular dyssynchrony are common in heart failure patients, regardless of QRS duration. European Heart Journal 2004; 25:571–8.

Bleeker GB, Schalij MJ, Molhoek SG, et al. Relationship between QRS duration and left ventricular dyssynchrony in patients with end-stage heart failure. Journal of Cardiovascular Electrophysiology 2004;15:544–49.

Yu CM, Lin H, Zhang Q, Sanderson JE. High prevalence of left ventricular systolic and diastolic asynchrony in patients with congestive heart failure and normal QRS duration. Heart 2003;89:54–60.

Yu CM,FungWH,LinH,ZhangQ,SandersonJE,LauCP. Predictors of left ventricular reverse remodeling after cardiac resynchronization therapy for heart failure secondary to idiopathic dilated or ischemic cardiomyopathy. American Journal of Cardiology 2003;91:684–8.

Gold MR, Birgersdotter-Green U, Singh JP, et al. The relationship between ventricular electrical delay and left ventricular remodeling with cardiac resynchronization therapy. European Heart Journal 2011;32:2516–24.

European Heart Rhythm Association (EHRA); European Society of Cardiology (ESC); Heart Rhythm Society; et al. 2012. Expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommen dations and management. Europace 2012;14:1236–86.

Singh JP,KleinHU,HuangDT, et al. Left ventricular lead position and clinical outcome in the multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT) trial. Circulation 2011;123:1159–1166.31.

Merchant FM, Heist EK, McCarty D, et al. Impact of segmental left ventricle lead position on cardiac resynchronization therapy outcomes. Heart Rhythm 2010;7:639–44.

Linde C, Abraham WT, Gold MR, et al. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. Journal of the American College of Cardiology 2008;52:1834–43.

Adelstein EC, Saba S. Usefulness of baseline electro cardiographic QRS complex pattern to predict response to cardiac resynchronization. American Journal of Cardiology 2009;103: 238–42.

Poole JE, Singh JP, Birgersdotter-Green U. QRS Duration or QRS Morphology: What Really Matters in Cardiac Resynchronization Therapy? Journal of the American College of Cardiology 2016;67:1104–1117.

Upadhyay GA, Choudhry NK, Auricchio A, et al. Cardiac resynchronization in patients with atrial fibrillation. A meta-analysis of prospective cohort studies. Journal of the American College of Cardiology 2008;52:1239–46.

Chatterjee NA, Singh JP, Szymonifka J, et al. Incremental value of cystatin C over conventional renal metrics for predicting clinical response and outcomes in cardiac resynchronization therapy: The BIOCRTstudy. International Journal of Cardiology 2016;205:43–49.

Bose A, Kandala J, Upadhyay GA, et al. Impact of myocardial viability and left ventricular lead location on clinical outcome in cardiac resynchronization therapy recipients with ischemic cardiomyopathy. Journal of Cardiovascular Electrophysiology 2014;25:507–13.

Linde C, Gold MR, Abraham WT, et al. Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left ventricular dysfunction (REVERSE) study. European Heart Journal 2013;34:2592–9.

Saba S, Marek J, Schwartzman D, et al. Echocardiography-guided left ventricular lead placement for cardiac resynchronization therapy: results of the Speckle Tracking Assisted Resynchronization Therapy for Electrode Region trial. Circulation: Heart Failure 2013;6:427-34.

Kandala J, Upadhyay GA, Altman RK, et al. QRS morphology, left ventricular lead location, and clinical outcome in patients receiving cardiac resynchronization therapy. European Heart Journal 2013;34:2252–62.

Leyva F, Taylor RJ, Foley PW, et al. Left ventricular mid wall fibrosis as a predictor of mortality and morbidity after cardiac resynchronization therapy in patients with nonischemic cardiomyopathy. Journal of the American College of Cardiology 2012;60:1659–67.

Zanon F, Baracca E, Pastore G, et al. Multipoint pacing by a left ventricular quadripolar lead improves the acute hemodynamic response to CRT compared with conventional biventricular pacing at any site. Heart Rhythm 2015;12:975–81.

Sweeney MO, van Bommel RJ, Schalij MJ, et al. Analysis of ventricular activation using surface electrocardiography to predict left ventricular reverse volumetric remodeling during cardiac resynchronization therapy. Circulation 2010;121:626–34.

Rickard J, Cheng A, Spragg D, et al. QRS narrowing is associated with reverse remodeling in patients with chronic right ventricular pacing upgraded to cardiac resynchronization therapy. Heart Rhythm 2013;10:55–60.

Ellenbogen KA, Gold MR, Meyer TE, et al. Primary results from the SmartDelay determined AV optimization: a comparison to other AV delay methods used in cardiac resynchronization therapy (SMART-AV) trial: a randomized trial comparing empirical, echocardiography-guided, and algorithmic atrioventricular delay programming in cardiac resynchronization therapy. Circulation. 2010;122:2660–8.

Varma N, Piccini JP, Snell J, Fischer A, Dalal N, Mittal S. The Relationship Between Level of Adherence to Automatic Wireless Remote Monitoring and Survival in Pacemaker and Defibrillator Patients. Journal of the American College of Cardiology 2015;65:2601–10.

Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/ HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmic Devices). Circulation 2008;117:e350–408.

Rickard J, Cheng A, Spragg D, et al. Durability of the survival effect of cardiac resynchronization therapy by level of left ventricular functional improvement: fate of ‘‘nonresponders’’. Heart Rhythm 2014;11:412–6.

Zareba W, Klein H, Cygankiewicz I, et al. MADIT-CRT Investigators. Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT). Circulation 2011;123(10):1061–1072.

Varma N, Manne M, Nguyen D, et al. Probability and magnitude of response to cardiac resynchronization therapy according to QRS duration and gender in nonischemic cardiomyopathy and LBBB. Heart Rhythm 2014;11:1139–47.

Leyva F, Foley PW, Chalil S, et al. Cardiac resynchronization therapy guided by late gadolinium-enhancement cardiovascular magnetic resonance. Journal of Cardiovascular Magnetic Resonance 2011;13:29.

Cleland JG, Daubert JC, Erdmann E, et al; Cardiac Resyn-chronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. New England Journal of Medicine 2005;352:1539–49.

Yu CM, Chau E, Sanderson JE, et al. Tissue Doppler echo-cardiographic evidence of reverse remodeling and improved synchronicity by simultaneously delaying regional contraction after biventricular pacing therapy in heart failure. Circulation. 2002;105:438–45.

Bax JJ, Abraham T, Barold SS, et al. Cardiac resynchronization therapy: Part 1–issues before device implantation. Journal of the American College of Cardiology 2005;46:2153–67.

Ghio S, Constantin C, Klersy C, et al. Interventricular and intraventricular dyssynchrony are common in heart failure patients, regardless of QRS duration. European Heart Journal 2004; 25:571–8.

Bleeker GB, Schalij MJ, Molhoek SG, et al. Relationship between QRS duration and left ventricular dyssynchrony in patients with end-stage heart failure. Journal of Cardiovascular Electrophysiology 2004;15:544–49.

Yu CM, Lin H, Zhang Q, Sanderson JE. High prevalence of left ventricular systolic and diastolic asynchrony in patients with congestive heart failure and normal QRS duration. Heart 2003;89:54–60.

Yu CM,FungWH,LinH,ZhangQ,SandersonJE,LauCP. Predictors of left ventricular reverse remodeling after cardiac resynchronization therapy for heart failure secondary to idiopathic dilated or ischemic cardiomyopathy. American Journal of Cardiology 2003;91:684–8.

Gold MR, Birgersdotter-Green U, Singh JP, et al. The relationship between ventricular electrical delay and left ventricular remodeling with cardiac resynchronization therapy. European Heart Journal 2011;32:2516–24.

European Heart Rhythm Association (EHRA); European Society of Cardiology (ESC); Heart Rhythm Society; et al. 2012. Expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommen dations and management. Europace 2012;14:1236–86.

Singh JP,KleinHU,HuangDT, et al. Left ventricular lead position and clinical outcome in the multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT) trial. Circulation 2011;123:1159–1166.31.

Merchant FM, Heist EK, McCarty D, et al. Impact of segmental left ventricle lead position on cardiac resynchronization therapy outcomes. Heart Rhythm 2010;7:639–44.

Linde C, Abraham WT, Gold MR, et al. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. Journal of the American College of Cardiology 2008;52:1834–43.

Adelstein EC, Saba S. Usefulness of baseline electro cardiographic QRS complex pattern to predict response to cardiac resynchronization. American Journal of Cardiology 2009;103: 238–42.

Poole JE, Singh JP, Birgersdotter-Green U. QRS Duration or QRS Morphology: What Really Matters in Cardiac Resynchronization Therapy? Journal of the American College of Cardiology 2016;67:1104–1117.

Upadhyay GA, Choudhry NK, Auricchio A, et al. Cardiac resynchronization in patients with atrial fibrillation. A meta-analysis of prospective cohort studies. Journal of the American College of Cardiology 2008;52:1239–46.

Chatterjee NA, Singh JP, Szymonifka J, et al. Incremental value of cystatin C over conventional renal metrics for predicting clinical response and outcomes in cardiac resynchronization therapy: The BIOCRTstudy. International Journal of Cardiology 2016;205:43–49.

Bose A, Kandala J, Upadhyay GA, et al. Impact of myocardial viability and left ventricular lead location on clinical outcome in cardiac resynchronization therapy recipients with ischemic cardiomyopathy. Journal of Cardiovascular Electrophysiology 2014;25:507–13.

Linde C, Gold MR, Abraham WT, et al. Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left ventricular dysfunction (REVERSE) study. European Heart Journal 2013;34:2592–9.

Saba S, Marek J, Schwartzman D, et al. Echocardiography-guided left ventricular lead placement for cardiac resynchronization therapy: results of the Speckle Tracking Assisted Resynchronization Therapy for Electrode Region trial. Circulation: Heart Failure 2013;6:427-34.

Kandala J, Upadhyay GA, Altman RK, et al. QRS morphology, left ventricular lead location, and clinical outcome in patients receiving cardiac resynchronization therapy. European Heart Journal 2013;34:2252–62.

Leyva F, Taylor RJ, Foley PW, et al. Left ventricular mid wall fibrosis as a predictor of mortality and morbidity after cardiac resynchronization therapy in patients with nonischemic cardiomyopathy. Journal of the American College of Cardiology 2012;60:1659–67.

Zanon F, Baracca E, Pastore G, et al. Multipoint pacing by a left ventricular quadripolar lead improves the acute hemodynamic response to CRT compared with conventional biventricular pacing at any site. Heart Rhythm 2015;12:975–81.

Sweeney MO, van Bommel RJ, Schalij MJ, et al. Analysis of ventricular activation using surface electrocardiography to predict left ventricular reverse volumetric remodeling during cardiac resynchronization therapy. Circulation 2010;121:626–34.

Rickard J, Cheng A, Spragg D, et al. QRS narrowing is associated with reverse remodeling in patients with chronic right ventricular pacing upgraded to cardiac resynchronization therapy. Heart Rhythm 2013;10:55–60.

Ellenbogen KA, Gold MR, Meyer TE, et al. Primary results from the SmartDelay determined AV optimization: a comparison to other AV delay methods used in cardiac resynchronization therapy (SMART-AV) trial: a randomized trial comparing empirical, echocardiography-guided, and algorithmic atrioventricular delay programming in cardiac resynchronization therapy. Circulation. 2010;122:2660–8.

Varma N, Piccini JP, Snell J, Fischer A, Dalal N, Mittal S. The Relationship Between Level of Adherence to Automatic Wireless Remote Monitoring and Survival in Pacemaker and Defibrillator Patients. Journal of the American College of Cardiology 2015;65:2601–10.